X
Xiaopeng Han
Researcher at Shenyang Pharmaceutical University
Publications - 20
Citations - 942
Xiaopeng Han is an academic researcher from Shenyang Pharmaceutical University. The author has contributed to research in topics: Prodrug & Intestinal absorption. The author has an hindex of 12, co-authored 19 publications receiving 771 citations.
Papers
More filters
Journal ArticleDOI
Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy
Cong Luo,Jin Sun,Dan Liu,Bingjun Sun,Lei Miao,Sara Musetti,Jing Li,Xiaopeng Han,Yuqian Du,Lin Li,Leaf Huang,Zhonggui He +11 more
TL;DR: This novel prodrug-nanosystem addresses concerns related to the low drug loading and inefficient drug release from hydrophobic prodrugs of PTX, and provides possibilities for the development of redox dual-sensitive conjugates or polymers for efficient anticancer drug delivery.
Journal ArticleDOI
Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: Probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation
Xiaopeng Han,Zhenbao Li,Jin Sun,Cong Luo,Lin Li,Yuhai Liu,Yuqian Du,Shuhong Qiu,Xiaoyu Ai,Chunnuan Wu,He Lian,Zhonggui He +11 more
TL;DR: The findings suggest that balancing long circulation property and cellular uptake is important to achieve the optimal antitumor efficacy for pegylated HA-based NPs, and that PEG coating densities cannot be extended beyond a certain density for shielding effect without compromising the efficacy of hyaluronic acid targeted delivery.
Journal ArticleDOI
Recent Advances in Platinum (IV) Complex-Based Delivery Systems to Improve Platinum (II) Anticancer Therapy
TL;DR: Recent advances in Pt (IV) complexes in combination with nanocarriers are highlighted, addressing the shortcomings of Pt ( IV) complexes, such as their instability in blood and irreversibly binding to plasma proteins and nonspecific distribution, and taking advantage of passive and active targeting effect to improve Pt (II) anticancer therapy.
Journal ArticleDOI
Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan-vitamin E succinate nanomicelles based on a mucus bioadhesion and penetration mechanism.
He Lian,Tianhong Zhang,Jin Sun,Xiaohong Liu,Guolian Ren,Longfa Kou,Youxi Zhang,Xiaopeng Han,Wenya Ding,Xiaoyu Ai,Chunnuan Wu,Lin Li,Yongjun Wang,Yinghua Sun,Siling Wang,Zhonggui He +15 more
TL;DR: The novel multifunctional CVN nanomicelles appear to be a promising nanocarrier for insoluble and poorly permeable drugs due to their high bioadhesion and permeation-enhancing capability.
Journal ArticleDOI
Nimodipine nanocrystals for oral bioavailability improvement: role of mesenteric lymph transport in the oral absorption.
Qiang Fu,Jin Sun,Xiaoyu Ai,Peng Zhang,Mo Li,Yongjun Wang,Xiaohong Liu,Yinghua Sun,Xiaofan Sui,Le Sun,Xiaopeng Han,Meng Zhu,Yuyang Zhang,Siling Wang,Zhonggui He +14 more
TL;DR: The permeability of nanocry crystals in duodenum, ileum and colon was not superior to that of Nimotop(®), suggestive of special absorption mechanisms involved, and it was impossible to establish a favorable in vitro in vivo correlation for NMD nanocrystals and Nimotup(®).